Metformin Viatris

Metformin Hydrochloride, the active ingredient in Metformin Viatris, is a biguanide presented as an oral tablet for oral use. It treats type 2 diabetes mellitus by improving blood glucose control in adults and adolescents. GNH USA supplies Metformin Viatris as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Viatris is an oral antidiabetic agent used in the management of glucose metabolism disorders. - Type 2 diabetes in adults: lowers fasting and post‑prandial blood glucose levels. - Type 2 diabetes in adolescents (≥10 years): improves glycaemic control when diet and exercise are insufficient. - Prediabetes or impaired glucose tolerance: reduces the risk of progression to overt diabetes.

Metformin Viatris may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: frequent loose stools, especially at therapy initiation. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception. - Loss of appetite: reduced desire to eat. - Vitamin B12 deficiency: decreased absorption with long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic acidosis. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: marked elevation of liver enzymes. - Hypoglycaemia: when combined with insulin or secretagogues. - Pancreatitis: inflammation of the pancreas. - Anemia: due to folate deficiency with prolonged therapy.

Metformin Viatris requires careful patient assessment and monitoring. - Renal function: evaluate creatinine clearance before starting and periodically thereafter. - Hepatic disease: avoid in patients with severe liver impairment. - Alcohol consumption: limit intake to reduce risk of lactic acidosis. - Risk of lactic acidosis: monitor for unexplained fatigue, myalgia, dyspnoea, or abdominal pain. - Pregnancy and lactation: discuss potential benefits and risks with a healthcare professional. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Metformin Viatris can interact with several medicines, influencing its safety and efficacy.

Major Interactions (Avoid): - Iodinated contrast agents: increase risk of lactic acidosis; discontinue metformin before and after imaging. - Cimetidine: may raise metformin plasma concentrations. - Nitrates: combined use can predispose to lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - Diuretics: can affect renal clearance of metformin. - ACE inhibitors or ARBs: monitor renal function and electrolytes.